YD Bio Ltd (YDES)

US · Healthcare · Biotechnology

$3.24-12.43%

Last close · 2026-09-17

Latest quarter · ended 2025-06-30

Net profit

$-2.2M

Profit YoY

-112.9%

EPS

$-0.65

Market cap

$271.3M

P/E

0.0

Forward P/E

0.0

P/B

61.44

Book value

$4.57

EPS (TTM)

$0.00

52-week high

$22.00

52-week low

$1.70

50-day MA

$3.02

200-day MA

$6.65

Beta

-0.03

Insiders

80.12%

Institutions

0.40%

Fund	Stake
Garrett Wealth Advisory Group, LLC	0.12%
Geode Capital Management, LLC	0.09%
Cypress Capital Management, LLC	0.05%
HPM Partners LLC	0.05%
Citadel Advisors Llc	0.03%
UBS Group AG	0.02%
Wolverine Asset Management LLC	0.01%
Morgan Stanley - Brokerage Accounts	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for YD Bio Ltd — free to start.

Data updated 2026-09-18.